Table 3 Correlations of OS with clinic-pathologic characteristics in LUAD patients estimated using multivariate Cox regression analysis.

From: Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma

Clinicopathologic variable

OS

HR (95%CI)

p value

Age

1.00 (0.98–1.02)

0.843

Gender

1.04 (0.72–1.49)

0.852

Stage

1.65 (1.40–1.95)

0.000

T

1.63 (1.32–2.02)

0.000

M

1.76 (0.96–3.20)

0.066

N

1.79 (1.46–2.20)

0.000

MND1

1.45 (1.14–1.84)

0.002

  1. OS overall survival, HR hazard ratio, 95%CI 95% confidence interval.
Back to article page